IQVIA, a Durham, N.C.-based healthcare technology and contract research services provider, led the funding round with major participation by EW Healthcare Partners, a New York City-based pharmaceutical company focused on oncology.
New York City-based Memorial Sloan Kettering Cancer Center also participated in the funding round, along with a group of existing investors. Memorial Sloan Kettering entered into a multiyear partnership with Cota in November, under which the cancer center will provide the startup with anonymized clinical data.
Cota’s leadership team plans to use the Series C funding to scale its solution across healthcare providers, payers and life sciences companies. Cota’s solution helps healthcare organizations apply precision medicine by categorizing patient demographic factors, diseases and therapies.
More articles on data analytics & precision medicine:
Report: Annual VC investment in genomics companies rises 142% since 2016
Cedars-Sinai researchers investigate ‘patient-on-a-chip’ tech to drive precision medicine
Survey: More than 80% of payers integrate social determinants of health data into programs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
